231 related articles for article (PubMed ID: 19670459)
21. Adipose tissue dysfunction increases fatty liver association with pre diabetes and newly diagnosed type 2 diabetes mellitus.
Jorge-Galarza E; Medina-Urrutia A; Posadas-Sánchez R; Posadas-Romero C; Cardoso-Saldaña G; Vargas-Alarcón G; Caracas-Portilla N; González-Salazar C; Torres-Tamayo M; Juárez-Rojas JG
Diabetol Metab Syndr; 2016; 8():73. PubMed ID: 27843495
[TBL] [Abstract][Full Text] [Related]
22. Depletion of fat-resident Treg cells prevents age-associated insulin resistance.
Bapat SP; Myoung Suh J; Fang S; Liu S; Zhang Y; Cheng A; Zhou C; Liang Y; LeBlanc M; Liddle C; Atkins AR; Yu RT; Downes M; Evans RM; Zheng Y
Nature; 2015 Dec; 528(7580):137-41. PubMed ID: 26580014
[TBL] [Abstract][Full Text] [Related]
23. Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial.
Musso G; Pinach S; Mariano F; Saba F; De Michieli F; Framarin L; Berrutti M; Paschetta E; Parente R; Lizet Castillo Y; Leone N; Castellino F; Cassader M; Gambino R
Hepatology; 2024 May; ():. PubMed ID: 38809154
[TBL] [Abstract][Full Text] [Related]
24. Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention.
Suppli MP; Høgedal A; Bagger JI; Chabanova E; van Hall G; Forman JL; Christensen MB; Albrechtsen NJW; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2024 Mar; 109(4):955-967. PubMed ID: 37967235
[TBL] [Abstract][Full Text] [Related]
25. The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial.
Shields WW; Thompson KE; Grice GA; Harrison SA; Coyle WJ
Therap Adv Gastroenterol; 2009 May; 2(3):157-63. PubMed ID: 21180541
[TBL] [Abstract][Full Text] [Related]
26. Adipose Tissue Insulin Resistance in South Asian and Nordic Women after Gestational Diabetes Mellitus.
Kvist AAS; Sharma A; Sommer C; Qvigstad E; Gulseth HL; Sollid ST; Nermoen I; Sattar N; Gill J; Tannæs TM; Birkeland KI; Lee-Ødegård S
Metabolites; 2024 May; 14(5):. PubMed ID: 38786765
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.
de la Monte SM; Longato L; Tong M; Wands JR
Curr Opin Investig Drugs; 2009 Oct; 10(10):1049-60. PubMed ID: 19777393
[TBL] [Abstract][Full Text] [Related]
28. Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis.
Azeemuddin M; Rafiq M; Anturlikar SD; Sharath Kumar LM; Patki PS; Babu UV; Shyam R
J Tradit Complement Med; 2016 Apr; 6(2):160-7. PubMed ID: 27114939
[TBL] [Abstract][Full Text] [Related]
29. Pioglitazone: Indian perspective.
Shukla R; Kalra S
Indian J Endocrinol Metab; 2011 Oct; 15(4):294-7. PubMed ID: 22029000
[TBL] [Abstract][Full Text] [Related]
30. Lupin protein isolate improves insulin sensitivity and steatohepatitis in vivo and modulates the expression of the
Soto-Luna IC; García-López PM; Vargas-Guerrero B; Guzmán TJ; Domínguez-Rosales JA; Gurrola-Díaz CM
Food Sci Nutr; 2021 May; 9(5):2549-2560. PubMed ID: 34026071
[TBL] [Abstract][Full Text] [Related]
31. Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study.
Bell LN; Wang J; Muralidharan S; Chalasani S; Fullenkamp AM; Wilson LA; Sanyal AJ; Kowdley KV; Neuschwander-Tetri BA; Brunt EM; McCullough AJ; Bass NM; Diehl AM; Unalp-Arida A; Chalasani N;
Hepatology; 2012 Oct; 56(4):1311-8. PubMed ID: 22532269
[TBL] [Abstract][Full Text] [Related]
32. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
[TBL] [Abstract][Full Text] [Related]
33. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Sanyal AJ; Chalasani N; Kowdley KV; McCullough A; Diehl AM; Bass NM; Neuschwander-Tetri BA; Lavine JE; Tonascia J; Unalp A; Van Natta M; Clark J; Brunt EM; Kleiner DE; Hoofnagle JH; Robuck PR;
N Engl J Med; 2010 May; 362(18):1675-85. PubMed ID: 20427778
[TBL] [Abstract][Full Text] [Related]
34. How to Measure Adipose Tissue Insulin Sensitivity.
Søndergaard E; Espinosa De Ycaza AE; Morgan-Bathke M; Jensen MD
J Clin Endocrinol Metab; 2017 Apr; 102(4):1193-1199. PubMed ID: 28323973
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.
Cusi K; Orsak B; Bril F; Lomonaco R; Hecht J; Ortiz-Lopez C; Tio F; Hardies J; Darland C; Musi N; Webb A; Portillo-Sanchez P
Ann Intern Med; 2016 Sep; 165(5):305-15. PubMed ID: 27322798
[TBL] [Abstract][Full Text] [Related]
36. Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study.
Gastaldelli A; Gaggini M; DeFronzo RA
Diabetes; 2017 Apr; 66(4):815-822. PubMed ID: 28052966
[TBL] [Abstract][Full Text] [Related]
37. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
Scorletti E; Bhatia L; McCormick KG; Clough GF; Nash K; Hodson L; Moyses HE; Calder PC; Byrne CD;
Hepatology; 2014 Oct; 60(4):1211-21. PubMed ID: 25043514
[TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R
Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858
[TBL] [Abstract][Full Text] [Related]
39. Pioglitazone in the treatment of NASH: the role of adiponectin.
Gastaldelli A; Harrison S; Belfort-Aguiar R; Hardies J; Balas B; Schenker S; Cusi K
Aliment Pharmacol Ther; 2010 Sep; 32(6):769-75. PubMed ID: 20662773
[TBL] [Abstract][Full Text] [Related]
40. Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.
Bril F; Kalavalapalli S; Clark VC; Lomonaco R; Soldevila-Pico C; Liu IC; Orsak B; Tio F; Cusi K
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):558-566.e2. PubMed ID: 29223443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
